Skip to main content
. 2016 Sep 12;7(43):69770–69782. doi: 10.18632/oncotarget.11974

Figure 7. The effect of Cdc20 downregulation on cell migration in glioma cells.

Figure 7

(A) Left panel: The wound healing assay was conducted to detect the cell migration in glioma cells after Cdc20 shRNA and rottlerin treatment. Control: siRNA control; Rottlerin: 2 μM rottlerin; shRNA: Cdc20 shRNA; Both: rottlerin + Cdc20 shRNA. Right panel: Quantitative results are illustrated for left panel. *P < 0.05, vs control; #P < 0.05 vs Cdc20 shRNA treatment or rottlerin treatment. (B) Left panel: The expression of Cdc20 and its target p21 was detected by western blotting in glioma cells with Cdc20 shRNA and rottlerin treatment. Right panel: Quantitative results are illustrated for left panel. *P < 0.05, **P < 0.01, compared with control; #P < 0.05 compared with rottlerin treatment or Cdc20 shRNA treatment.